Health Informatics and Resistance Exercise for Symptom Management and Quality of Life in Post-Esophagectomy Patients
Effects of Health Informatics for Symptom Management and Resistance Exercise Strategies on Quality of Life and Sarcopenia in Post-Esophagectomy Patients With Esophageal Cancer: A Mixed-Methods Study
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
Participants are invited to take part in a research study. In accordance with the requirements of the health authorities, participants must be informed of the purpose of the study and its potential risks. Participation is voluntary, and each participant is free to decide whether or not to enroll. The study may be discussed with trusted individuals, and sufficient time may be taken to consider the decision. If any part of this consent form is unclear, questions may be directed to the principal investigator or the research team, who will provide an explanation. If a participant chooses not to participate, appropriate treatment will still be provided. Even if a participant agrees to participate initially, withdrawal is allowed at any time without affecting medical rights or the care that should be received.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2025
CompletedFirst Posted
Study publicly available on registry
September 18, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2027
September 18, 2025
August 1, 2025
1.8 years
August 19, 2025
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of Life (EORTC QLQ-C30 score)
The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) is a validated and widely used instrument for assessing quality of life in patients with cancer. It includes five functional scales (physical, role, emotional, cognitive, and social), three symptom scales (fatigue, pain, and nausea/vomiting), a global health status/quality of life scale, and several single-item symptom measures (dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties). Scores are linearly transformed to a 0-100 scale; higher scores on functional and global health scales indicate better functioning/quality of life, whereas higher scores on symptom scales indicate greater symptom burden.
Baseline, 1 month, 3 months, 6 months after intervention
Secondary Outcomes (3)
Esophageal Cancer-related Symptoms (EORTC QLQ-OES18 score)
1 month, 3 months, 6 months after intervention
Sarcopenia Status (e.g., SARC-F or handgrip strength, muscle mass index)
Baseline, 1 month, 3 months, 6 months after intervention
Body Mass Index (BMI)
Baseline, 1 month, 3 months, 6 months after intervention
Study Arms (2)
Usual Care Group
ACTIVE COMPARATORParticipants receive standard postoperative nursing care and education as routinely provided by the clinical team. No additional interventions will be given.
Symptom Management Health Informatics plus Resistance Exercise Group
EXPERIMENTALParticipants receive access to a symptom management health informatics program and a structured resistance band exercise training program.
Interventions
Access to educational videos and an instant messaging platform for real-time communication, delivered over 12 weeks. plus Structured resistance band exercise, 3 times per week, \~30 minutes per session, for 12 weeks under research team guidance.
Standard postoperative nursing care and education routinely provided by the clinical team. No additional interventions will be given.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Diagnosed with esophageal cancer and having undergone esophagectomy
- Postoperative pathological report confirms R0 resection (complete tumor removal)
- Able to be discharged after surgery
- With or without adjuvant chemoradiotherapy
- Clear consciousness and able to communicate in Mandarin or Taiwanese
You may not qualify if:
- Presence of severe cardiovascular disease or psychiatric disorders
- Inability to communicate in Mandarin Chinese or Taiwanese
- Disease progression during the intervention period that prevents continuation of participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Chang YL, Tsai YF, Chao YK, Wu MY. Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer. Qual Life Res. 2016 Feb;25(2):465-475. doi: 10.1007/s11136-015-1094-4. Epub 2015 Aug 4.
PMID: 26238649BACKGROUNDChang YL, Tsai YF, Wu YC, Hsieh MJ. Factors relating to quality of life after esophagectomy for cancer patients in Taiwan. Cancer Nurs. 2014 Jan-Feb;37(1):4-13. doi: 10.1097/NCC.0b013e318277dc53.
PMID: 23357884BACKGROUNDChang YL, Tsai YF, Hsu CL, Chao YK, Hsu CC, Lin KC. The effectiveness of a nurse-led exercise and health education informatics program on exercise capacity and quality of life among cancer survivors after esophagectomy: A randomized controlled trial. Int J Nurs Stud. 2020 Jan;101:103418. doi: 10.1016/j.ijnurstu.2019.103418. Epub 2019 Sep 11.
PMID: 31670173BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 19, 2025
First Posted
September 18, 2025
Study Start
October 1, 2025
Primary Completion (Estimated)
July 31, 2027
Study Completion (Estimated)
July 31, 2027
Last Updated
September 18, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share